Schedule 13D ownership disclosure

aTYR PHARMA INC

Security class unavailable · CUSIP: 002120103

Event date: 2018-08-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,600,962
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001564590-18-022883
Form type
SC 13D
Filer
SCHIMMEL PAUL
CIK
CIK 1236447
Filed
Sep 10, 2018
Reporting period
Aug 30, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub